Lupus Clinical Trials in San Antonio

Showing 61-80 of 85 trials

Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder

NCT02871427

This study seeks to evaluate the long-term safety and effectiveness of nelotanserin for the treatment of visual hallucinations (VHs) and Rapid Eye Movement (REM) Sleep Behavior Disorder (RBD) in subjects with Lewy body dementia (LBD).

Lewy Body DementiaDementia With Lewy BodiesParkinson's Disease Dementia+2 more

Axovant Sciences Ltd.80 participantsStarted Oct 2016

Birmingham, Alabama, United States • Little Rock, Arkansas, United States • Boca Raton, Florida, United States +16 more locations

TERMINATEDPHASE3< 1 mile

A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus

NCT02041091

The purpose of this study is to evaluate the amount of tabalumab in the blood after it is given by two different injection methods - A traditional syringe or a spring loaded syringe for 12 weeks. Participants may continue to receive study drug for up to 52 weeks.

Lupus Erythematosus, Systemic

Eli Lilly and Company226 participantsStarted Jan 2014

Covina, California, United States • El Cajon, California, United States • Long Beach, California, United States +41 more locations

Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder

A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus

Lupus Trials in Other Cities

Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older

A Study of Belimumab in Subjects With Systemic Lupus Erythematosus

Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age

PROVIGIL® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome

A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)

Dose Ranging Study of Brentuximab Vedotin in Adults With Lupus

MSC2364447C Phase 1b in Systemic Lupus Erythematosus

A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus

A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Participants With Systemic Lupus Erythematosus or Myositis

Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions

Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder

PEARL-SC Trial: A Study of the Efficacy, Safety, and Tolerability of A 623 Administration in Subjects With Systemic Lupus Erythematosus

Oxygen Monitoring of Patients After Surgery on the Hospital General Care Floor

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ABT-199 in Female Patients With Systemic Lupus Erythematosus (SLE)

Study of Epratuzumab in Systemic Lupus Erythematosus

A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers

The POSAtive Study: Study for the Treatment of Positional Obstructive Sleep Apnea

Safety Study of AMG 557 in Subjects With Lupus Arthritis

Other Conditions in San Antonio